Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPH

NCT07722884 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07722884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07722884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPH
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2026
Completion date
January 1, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, efficacy, lower urinary tract symptoms, monotherapy, safety, tadalafil, tamsulosin